Fludarabine phosphate oral tablets

Fludarabine phosphate oral tablets
Trade Name
Orphan Indication Chronic lymphocytic leukemia
USA Market Approval USA
USA Designation Date 2007-12-18 00:00:00
Sponsor Sanofi-Aventis U.S., Inc.;55 Corproate Drive, P. O. Box 5925;Bridgewater, New Jersey, 08807